Latest Headlines
Stereotactic radiation controls early stage lung cancer
Melanoma survivors at higher risk of other cancers
Cladribine and fludarabine equally helpful for progressive CLL
More frequent surveillance reduces colon cancer risk in Lynch syndrome families
Radiation can be avoided in early Hodgkin's lymphoma
NEWS PROVIDED BY 
VIEW ALL NEWSGardasil vaccine seems okay for men: FDA
WASHINGTON (Reuters) - Merck & Co's Gardasil vaccine appears to be safe and effective in preventing genital warts in young men and boys, a U.S. medical reviewer said in documents released on Friday.
A U.S. Food and Drug Administration staff reviewer said the company's data showed the vaccine, already approved for use in girls and young women, was effective in preventing the warts caused by certain strains of the human papillomavirus.
The company is seeking the FDA's permission to market Gardasil for males between 9 and 26 years old, the same age rage currently approved for females.
The FDA released the staffer's memo ahead of an advisory panel meeting on Wednesday to discuss whether to approve the new use. The agency usually follows its panelists' recommendations.
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
NEWS PROVIDED BY
TEXT SIZE 